M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Collins named principal in biotech investment banking group of Piper Jaffray
25 June 2014 - Minneapolis US-based investment bank and asset management firm Piper Jaffray (NYSE: PJC) said that Chris Collins has joined the firm as a principal in its biotechnology investment banking group.
His experience includes more than 14 years in financial services including 12...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives